Search results
Results from the WOW.Com Content Network
Use appears to be safe during pregnancy. [7] [1] It is classified as an osmotic laxative: [2] It works by increasing the amount of water in the stool. [3] Macrogol came into use as a bowel prep in 1980 and was approved for medical use in the United States in 1999. [8] [9] [10] It is available as a generic medication and over the counter.
Docusate is the common chemical and pharmaceutical name of the anion bis(2-ethylhexyl) sulfosuccinate, also commonly called dioctyl sulfosuccinate (DOSS). [2] [3] [4]Salts of this anion, especially docusate sodium, are widely used in medicine as laxatives and as stool softeners, by mouth or rectally. [1]
However, not all of them are safe to use during pregnancy. One of the components of bismuth subsalicylate is salicylate, which is a component that crosses the placenta. Due to this, there is an increased risk for intrauterine growth retardation, fetal hemorrhage, and maternal hemorrhage within organogenesis and in the second/third trimester. [ 12 ]
Because of the lack of research on Botox use during pregnancy, the FDA has classified it as a category C drug, “meaning there is little research to determine if it is safe during pregnancy ...
The growing popularity of drugs like Ozempic, Mounjaro and Wegovy, designed to help people with Type 2 diabetes and obesity, has raised new questions about what those drugs could mean for ...
Much like The Wizard of Oz, the first Wicked movie is designed for the whole family: kids can enjoy its colorful world-building and bubbly characters, adults can appreciate its timely real-world ...
It is a first-line treatment for amebiasis or giardiasis during pregnancy. [3] Otherwise, it is generally a second line treatment option. [3] It is taken by mouth, applied to the skin, or by injection into a muscle. [3] Common side effects when taken by mouth include loss of appetite, vomiting, abdominal pain, and diarrhea. [3]
[11] [12] [13] Maternal valproate use during pregnancy increased the probability of autism in the offspring compared to mothers not taking valproate from 1.5% to 4.4%. [14] A 2005 study found rates of autism among children exposed to sodium valproate before birth in the cohort studied were 8.9%. [ 15 ]